What is Myriad Genetics's net change in cash?

Myriad Genetics (MYGN) reported net change in cash of -$25.3M in Q1 2026.

How has Myriad Genetics's net change in cash changed year-over-year?

Myriad Genetics's net change in cash decreased by 132.1% year-over-year, from -$10.9M to -$25.3M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Myriad Genetics MYGN Net Change in Cash

Net Change in Cash at other companies

Labcorp HoldingsLH

$448.8M+139%

Quest DiagnosticsDGX

-$27M+92.5%

NeoGenomicsNEO

-$13.48M+35.3%

VeracyteVCYT

-$99.43M-88.1%

Guardant HealthGH

$612.02M+252%

Natera, Inc.NTRA

$11.79M-58.2%

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Reported directly by Myriad Genetics in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's net change in cash?: Myriad Genetics (MYGN) reported net change in cash of -$25.3M in Q1 2026.
How has Myriad Genetics's net change in cash changed year-over-year?: Myriad Genetics's net change in cash decreased by 132.1% year-over-year, from -$10.9M to -$25.3M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.